Johnson & Johnson (JNJ: NYSE)
$97.5 -0.18 | -0.18%
06/30/15 - 03:36 PM ET
Portfolios with JNJ
- Portfolio NameUser Type
- ProJohn Hussman - Hussman Stra...
- ProKen Fisher - Fisher Investm...
- ProJoel Greenblatt - Gotham Ca...
- ProJames Barrow - Barrow Hanle...
- ProDonald Yacktman - Yacktman ...
- ProBrian Rogers - T. Rowe Pric...
- ProPrem Watsa - Fairfax Financ...
- ProAdage Capital
- ProAcropolis Investment Manage...
- ContributorRocket Stocks for the Week ...
Latest JNJ Headlines from TheStreet
- 10 Dream Mergers; Fed's Greek Problem; Up Side of Negativity: Jim Cramer's Best Blogs 06.19.15 | 09:06 pm
- Apple and 10 Big Companies That Hoard the Most Cash 06.18.15 | 09:06 am
- Jim Cramer's 'Mad Money' Recap: Here Are My Dream Mergers 06.16.15 | 08:06 pm
- 3 Drugs Stocks Pushing Industry Growth 06.16.15 | 01:06 pm
- Dow Jones (DJIA) Today: Johnson & Johnson (JNJ) Lower 06.12.15 | 02:06 pm
- The 7 Best CEOs of Huge Consumer Companies 06.10.15 | 11:06 am
- Jim Cramer's 'Mad Money' Recap: Meet the Newest Cult Stock 06.08.15 | 07:06 pm
- JNJ, MMM, PVH, HD: Jim Cramer's Views 06.08.15 | 01:06 am
- 3 High-Yield, Low-Risk Dividend Stocks for Extreme Safety 05.27.15 | 12:05 pm
- 3 Big Pharmaceutical Stocks to Buy Right Now 05.21.15 | 08:05 am
Press Releases for JNJ
- Johnson & Johnson to Host Investor Conference Call on Second-Quarter Results - PR Newswire 06.16.15 | 04:06 pm
- CEO And Director Of Huntsman Cancer Institute Dr. Mary Beckerle Joins Johnson & Johnson Board Of Directors - PR Newswire 06.09.15 | 04:06 pm
- Johnson & Johnson Announces Acceptance Of Binding Offer From Cardinal Health To Acquire Cordis - PR Newswire 05.28.15 | 08:05 am
- Johnson & Johnson To Participate In The Goldman Sachs 36th Annual Global Healthcare Conference - PR Newswire 05.27.15 | 09:05 am
- China Diabetes Management Devices Market Growth To Be Driven By Rise In Sedentary Lifestyle And Life Expectancy And Patient Compliant Technologies Especially For Insulin Pump And CGM - PR Newswire 05.20.15 | 10:05 am
- Johnson & Johnson Pharmaceutical Segment To Continue Driving Above-Industry Growth With Plans To File More Than 10 New Products By 2019, Each With Potential To Exceed $1 Billion In Revenue - PR Newswire 05.20.15 | 07:05 am
- Johnson & Johnson Announces NYU School Of Medicine Partnership To Evaluate Compassionate Use Of Investigational Medicines - PR Newswire 05.07.15 | 12:05 am
- Johnson & Johnson To Participate In The 2015 Deutsche Bank 40th Annual Health Care Conference - PR Newswire 04.30.15 | 09:04 am
- Johnson & Johnson Announces Further Patent And Trademark Office Action Related To REMICADE® - PR Newswire 04.29.15 | 04:04 pm
- India Joint Replacement Market To Grow In Double Digits Through 2020 - PR Newswire 04.27.15 | 12:04 pm
Partner Headlines for JNJ
- Bristol-Myers Squibb Company (BMY) Ex-Dividend Date Scheduled for July 01, 2015 - NASDAQ 06.30.15 | 01:06 pm
- Two big problems with generic-drug substitution - CNBC 06.23.15 | 03:06 pm
- Medicine's next frontier: The microbiome - CNBC 06.19.15 | 08:06 am
- Robot surgery market set to change - Financial Times 06.17.15 | 05:06 am
- Peregrine Pharmaceuticals Inc. (PPHMP) Ex-Dividend Date Scheduled for June 17, 2015 - NASDAQ 06.16.15 | 01:06 pm
- Theravance, Inc. (THRX) Ex-Dividend Date Scheduled for June 10, 2015 - NASDAQ 06.09.15 | 01:06 pm
- Phibro Animal Health Corporation (PAHC) Ex-Dividend Date Scheduled for June 01, 2015 - NASDAQ 05.29.15 | 01:05 pm
- Pfizer and AstraZeneca: one year after deal that never was - Financial Times 05.26.15 | 07:05 pm
- The Zacks Analyst Blog Highlights: Johnson & Johnson, AstraZeneca, ACADIA Pharmaceuticals, Actavis and Alkermes - Press Releases - Zacks 05.26.15 | 09:05 am
- Condom company in sticky situation over lube deal - CNBC 05.22.15 | 08:05 am